NCH2.DENCH2.DEXETRA
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +25.78% | +28.57% | -21.93% | -27.12% | -43.89% |
| Gross Profit Growth | +30.04% | +17.28% | +7.88% | +27.92% | -13.79% |
| EBITDA Growth | +0.00% | +0.00% | +250.00% | +62.16% | -94.44% |
| Operating Income Growth | +2400.00% | +0.00% | +0.00% | +0.00% | -140.00% |
| Net Income Growth | +221.43% | +0.00% | -134.48% | -93.75% | -133.33% |
| EPS Growth | +221.62% | +0.00% | -134.64% | -93.68% | -133.33% |
| EPS Diluted Growth | +221.62% | +0.00% | -134.64% | -93.68% | -133.33% |
| Weighted Average Shares Growth | -0.24% | -0.24% | -0.24% | +0.25% | +0.00% |
| Weighted Average Shares Diluted Growth | -0.24% | -0.24% | -0.24% | +0.25% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +250.00% | +0.00% | +0.00% | +0.00% | -97.14% |
| Free Cash Flow Growth | +208.51% | +0.00% | +0.00% | +0.00% | -117.24% |
| Receivables Growth | +86.60% | +61.32% | -25.30% | -42.54% | -55.25% |
| Inventory Growth | +23.47% | +35.95% | +54.62% | +40.82% | +13.25% |
| Asset Growth | +11.53% | +10.16% | +2.89% | -4.73% | -13.59% |
| Book Value per Share Growth | +2.97% | +3.73% | +2.14% | -0.43% | -2.09% |
| Debt Growth | +333.33% | +390.91% | +437.04% | +464.00% | +11.54% |
| R&D Expense Growth | +29.63% | -13.04% | -4.76% | +27.52% | +28.57% |
| SG&A Expenses Growth | +7.78% | -5.47% | +1.60% | +0.93% | +0.00% |